91 related articles for article (PubMed ID: 18399537)
1. Validation of in vitro cell culture models of the blood-brain barrier: tightness characterization of two promising cell lines.
Neuhaus W; Plattner VE; Wirth M; Germann B; Lachmann B; Gabor F; Noe CR
J Pharm Sci; 2008 Dec; 97(12):5158-75. PubMed ID: 18399537
[TBL] [Abstract][Full Text] [Related]
2. A novel tool to characterize paracellular transport: the APTS-dextran ladder.
Neuhaus W; Bogner E; Wirth M; Trzeciak J; Lachmann B; Gabor F; Noe CR
Pharm Res; 2006 Jul; 23(7):1491-501. PubMed ID: 16779707
[TBL] [Abstract][Full Text] [Related]
3. Identification of two immortalized cell lines, ECV304 and bEnd3, for in vitro permeability studies of blood-brain barrier.
Yang S; Mei S; Jin H; Zhu B; Tian Y; Huo J; Cui X; Guo A; Zhao Z
PLoS One; 2017; 12(10):e0187017. PubMed ID: 29059256
[TBL] [Abstract][Full Text] [Related]
4. APTS-labeled dextran ladder: a novel tool to characterize cell layer tightness.
Neuhaus W; Trzeciak J; Lauer R; Lachmann B; Noe CR
J Pharm Biomed Anal; 2006 Mar; 40(4):1035-9. PubMed ID: 16242879
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier in vitro models as tools in drug discovery: assessment of the transport ranking of antihistaminic drugs.
Neuhaus W; Mandikova J; Pawlowitsch R; Linz B; Bennani-Baiti B; Lauer R; Lachmann B; Noe CR
Pharmazie; 2012 May; 67(5):432-9. PubMed ID: 22764578
[TBL] [Abstract][Full Text] [Related]
6. Expression of Claudin-1, Claudin-3 and Claudin-5 in human blood-brain barrier mimicking cell line ECV304 is inducible by glioma-conditioned media.
Neuhaus W; Wirth M; Plattner VE; Germann B; Gabor F; Noe CR
Neurosci Lett; 2008 Dec; 446(2-3):59-64. PubMed ID: 18817843
[TBL] [Abstract][Full Text] [Related]
7. Transport of a GABAA receptor modulator and its derivatives from Valeriana officinalis L. s. l. across an in vitro cell culture model of the blood-brain barrier.
Neuhaus W; Trauner G; Gruber D; Oelzant S; Klepal W; Kopp B; Noe CR
Planta Med; 2008 Sep; 74(11):1338-44. PubMed ID: 18704879
[TBL] [Abstract][Full Text] [Related]
8. Alteration of the glycocalyx of two blood-brain barrier mimicking cell lines is inducible by glioma conditioned media.
Neuhaus W; Germann B; Plattner VE; Gabor F; Wirth M; Noe CR
Brain Res; 2009 Jul; 1279():82-9. PubMed ID: 19445905
[TBL] [Abstract][Full Text] [Related]
9. An ECV304 monoculture model for permeability assessment of blood-brain barrier.
Yang S; Jin H; Zhao Z
Neurol Res; 2018 Feb; 40(2):117-121. PubMed ID: 29100486
[TBL] [Abstract][Full Text] [Related]
10. Barrier functionality and transport machineries of human ECV304 cells.
Barar J; Gumbleton M; Asadi M; Omidi Y
Med Sci Monit; 2010 Jan; 16(1):BR52-60. PubMed ID: 20037486
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of human nasal RPMI 2650 cells grown at an air-liquid interface as a model for nasal drug transport studies.
Bai S; Yang T; Abbruscato TJ; Ahsan F
J Pharm Sci; 2008 Mar; 97(3):1165-78. PubMed ID: 17628494
[TBL] [Abstract][Full Text] [Related]
12. [Changes and regulatory mechanism of tight junction proteins in in vitro model of lead-induced blood-brain barrier injury].
Xu Y; Che H; Liu M; Ke T; Ma Y; Chen J; Hao X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Nov; 29(11):1141-6. PubMed ID: 24200059
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier cell line PBMEC/C1-2 possesses functionally active P-glycoprotein.
Neuhaus W; Stessl M; Strizsik E; Bennani-Baiti B; Wirth M; Toegel S; Modha M; Winkler J; Gabor F; Viernstein H; Noe CR
Neurosci Lett; 2010 Jan; 469(2):224-8. PubMed ID: 19963040
[TBL] [Abstract][Full Text] [Related]
14. A novel flow based hollow-fiber blood-brain barrier in vitro model with immortalised cell line PBMEC/C1-2.
Neuhaus W; Lauer R; Oelzant S; Fringeli UP; Ecker GF; Noe CR
J Biotechnol; 2006 Aug; 125(1):127-41. PubMed ID: 16730091
[TBL] [Abstract][Full Text] [Related]
15. Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness.
Cohen-Kashi Malina K; Cooper I; Teichberg VI
Brain Res; 2009 Aug; 1284():12-21. PubMed ID: 19501061
[TBL] [Abstract][Full Text] [Related]
16. Transport rankings of non-steroidal antiinflammatory drugs across blood-brain barrier in vitro models.
Novakova I; Subileau EA; Toegel S; Gruber D; Lachmann B; Urban E; Chesne C; Noe CR; Neuhaus W
PLoS One; 2014; 9(1):e86806. PubMed ID: 24466249
[TBL] [Abstract][Full Text] [Related]
17. In vitro models of the blood-brain barrier.
Czupalla CJ; Liebner S; Devraj K
Methods Mol Biol; 2014; 1135():415-37. PubMed ID: 24510883
[TBL] [Abstract][Full Text] [Related]
18. Effects of NMDA receptor modulators on a blood-brain barrier in vitro model.
Neuhaus W; Freidl M; Szkokan P; Berger M; Wirth M; Winkler J; Gabor F; Pifl C; Noe CR
Brain Res; 2011 Jun; 1394():49-61. PubMed ID: 21549356
[TBL] [Abstract][Full Text] [Related]
19. In vitro effect of the Phoneutria nigriventer spider venom on cell viability, paracellular barrier function and transcellular transport in cultured cell lines.
de Paula Le Sueur L; Collares-Buzato CB; Kalapothakis E; da Cruz-Höfling MA
Toxicon; 2005 Aug; 46(2):130-41. PubMed ID: 15949833
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of bEnd5 cell line as an in vitro model for the blood-brain barrier under normal and hypoxic/aglycemic conditions.
Yang T; Roder KE; Abbruscato TJ
J Pharm Sci; 2007 Dec; 96(12):3196-213. PubMed ID: 17828743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
